- Home
- PDEX vs KRRO Comparison
PDEX vs KRRO Comparison
Compare PDEX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDEX
- KRRO
- Stock Information
- Founded
- PDEX 1978
- KRRO 2014
- Country
- PDEX United States
- KRRO United States
- Employees
- PDEX N/A
- KRRO N/A
- Industry
- PDEX Medical/Dental Instruments
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- PDEX Health Care
- KRRO Health Care
- Exchange
- PDEX Nasdaq
- KRRO Nasdaq
- Market Cap
- PDEX 149.0M
- KRRO 147.4M
- IPO Year
- PDEX N/A
- KRRO 2019
- Fundamental
- Price
- PDEX $39.42
- KRRO $15.99
- Analyst Decision
- PDEX Strong Buy
- KRRO Strong Buy
- Analyst Count
- PDEX 1
- KRRO 7
- Target Price
- PDEX $56.00
- KRRO $85.67
- AVG Volume (30 Days)
- PDEX 45.3K
- KRRO 122.7K
- Earning Date
- PDEX 09-04-2025
- KRRO 08-12-2025
- Dividend Yield
- PDEX N/A
- KRRO N/A
- EPS Growth
- PDEX 379.10
- KRRO N/A
- EPS
- PDEX 2.76
- KRRO N/A
- Revenue
- PDEX $64,123,999.00
- KRRO $6,281,000.00
- Revenue This Year
- PDEX $26.92
- KRRO $65.08
- Revenue Next Year
- PDEX $4.48
- KRRO N/A
- P/E Ratio
- PDEX $14.16
- KRRO N/A
- Revenue Growth
- PDEX 29.65
- KRRO N/A
- 52 Week Low
- PDEX $18.30
- KRRO $10.29
- 52 Week High
- PDEX $70.26
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- PDEX 36.14
- KRRO 56.00
- Support Level
- PDEX $43.74
- KRRO $15.03
- Resistance Level
- PDEX $48.77
- KRRO $16.89
- Average True Range (ATR)
- PDEX 3.44
- KRRO 1.44
- MACD
- PDEX -1.19
- KRRO 0.00
- Stochastic Oscillator
- PDEX 16.68
- KRRO 66.52
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.